Holdings of GESIURIS HEALTHCARE & INNOVATION FI
GESIURIS ASSET MANAGEMENT, SGIIC, S.A. ·38 declared positions · as of Dec 31, 2025
Original filing · Net assets 17.9M € · Ten largest lines: 50 % of the equity sleeve
Sector breakdown
- Health care 80.4 %
- Technology 1.5 %
- Materials 1.4 %
- Unattributed 16.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- EUR 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 58.1 %
- CH 17.1 %
- GB 10.9 %
- ES 3.3 %
- DK 3.0 %
- FR 2.8 %
- JP 1.9 %
- AU 1.5 %
- IT 1.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 22 | 9.1M € | 58.07 % |
| 2 | CH | 6 | 2.7M € | 17.06 % |
| 3 | GB | 2 | 1.7M € | 10.90 % |
| 4 | ES | 1 | 509.3K € | 3.25 % |
| 5 | DK | 2 | 463.3K € | 2.96 % |
| 6 | FR | 1 | 442.6K € | 2.83 % |
| 7 | JP | 2 | 296.5K € | 1.90 % |
| 8 | AU | 1 | 239.7K € | 1.53 % |
| 9 | IT | 1 | 235.1K € | 1.50 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Roche Holding AG | 1M € | 5.76 % | |
| 2 | Johnson & Johnson | 951.4K € | 5.33 % | |
| 3 | AstraZeneca PLC | 858.3K € | 4.81 % | |
| 4 | GSK PLC | 847K € | 4.74 % | |
| 5 | Merck & Co Inc | 817.3K € | 4.58 % | |
| 6 | Novartis AG | 788.6K € | 4.42 % | |
| 7 | AbbVie Inc | 739.2K € | 4.14 % | |
| 8 | UnitedHealth Group Inc | 609.9K € | 3.42 % | |
| 9 | Bristol-Myers Squibb Co | 597K € | 3.34 % | |
| 10 | Thermo Fisher Scientific Inc | 582.1K € | 3.26 % | |
| 11 | Eli Lilly & Co | 576.4K € | 3.23 % | |
| 12 | Pfizer Inc | 519.4K € | 2.91 % | |
| 13 | Grifols SA | 509.3K € | 2.85 % | |
| 14 | Amgen Inc | 501.6K € | 2.81 % | |
| 15 | Sanofi SA | 442.6K € | 2.48 % | |
| 16 | Medtronic PLC | 417.1K € | 2.34 % | |
| 17 | Novo Nordisk A/S | 368K € | 2.06 % | |
| 18 | Elevance Health Inc | 328.3K € | 1.84 % | |
| 19 | Alcon AG | 312.6K € | 1.75 % | |
| 20 | Zoetis Inc | 299.9K € | 1.68 % | |
| 21 | IQVIA Holdings Inc | 282.1K € | 1.58 % | |
| 22 | Regeneron Pharmaceuticals, Inc. | 279.3K € | 1.56 % | |
| 23 | Align Technology Inc | 279.2K € | 1.56 % | |
| 24 | Straumann Holding AG | 240.9K € | 1.35 % | |
| 25 | CSL Ltd | 239.7K € | 1.34 % | |
| 26 | Amplifon SpA | 235.1K € | 1.32 % | |
| 27 | Veeva Systems Inc | 228.1K € | 1.28 % | |
| 28 | Viatris Inc | 225.8K € | 1.26 % | |
| 29 | Abbott Laboratories | 224K € | 1.25 % | |
| 30 | Halozyme Therapeutics Inc | 217.7K € | 1.22 % | |
| 31 | Gilead Sciences Inc | 162K € | 0.91 % | |
| 32 | Sonova Holding AG | 155.7K € | 0.87 % | |
| 33 | Hoya Corp | 154.5K € | 0.87 % | |
| 34 | Sandoz Group AG | 142.9K € | 0.80 % | |
| 35 | Daiichi Sankyo Co Ltd | 142K € | 0.80 % | |
| 36 | Alexandria Real Estate Equities, Inc. | 133.3K € | 0.75 % | |
| 37 | Vertex Pharmaceuticals Inc | 115.8K € | 0.65 % | |
| 38 | Novo Nordisk A/S | 95.3K € | 0.53 % |